Morelli, M. P., Basar, R., Marin, D., Huey, R. W., Banerjee, P. P., Willis, J., Morris, V. K., Rafei, H., Dasari, A., Kee, B. K., Zeller, B. E., Diao, S., Menter, D., Shpall, E. J., Kopetz, S., Rezvani, K. (2025). A phase Ib study of immunotherapy with ex-vivo pre-activated and expanded CBNK cells in combination with cetuximab, in patients with colorectal cancer (CRC) with minimal residual disease (MRD): Final report.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.176